EGFR and ovarian carcinoma: Other ligand-based CARs included follicle-stimulating hormone (FSH) CARs targeting the FSH receptor expressed on ovarian cancer cells [101], adnectins binding to the epidermal growth factor receptor (EGFR), together with the granulocyte-macrophage colony-stimulating factor (GM-CSF) relating to the GM-CSF receptor (CD116) [102].